BR0208566B1 - Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica - Google Patents
Derivados de Beta-Carbolina, Seu Uso, e composição FarmacêuticaInfo
- Publication number
- BR0208566B1 BR0208566B1 BRPI0208566-6B1A BR0208566A BR0208566B1 BR 0208566 B1 BR0208566 B1 BR 0208566B1 BR 0208566 A BR0208566 A BR 0208566A BR 0208566 B1 BR0208566 B1 BR 0208566B1
- Authority
- BR
- Brazil
- Prior art keywords
- beta
- pharmaceutical composition
- carboline derivatives
- carboline
- derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical class N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0108337.7A GB0108337D0 (en) | 2001-04-03 | 2001-04-03 | Organic compounds |
| PCT/EP2002/003624 WO2002081471A1 (en) | 2001-04-03 | 2002-04-02 | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR0208566A BR0208566A (pt) | 2004-03-30 |
| BR0208566B1 true BR0208566B1 (pt) | 2013-12-24 |
Family
ID=9912165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0208566-6B1A BR0208566B1 (pt) | 2001-04-03 | 2002-04-02 | Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6861430B2 (https=) |
| EP (1) | EP1377578B1 (https=) |
| JP (1) | JP4405732B2 (https=) |
| KR (1) | KR100564840B1 (https=) |
| CN (1) | CN1309721C (https=) |
| AR (1) | AR035451A1 (https=) |
| AT (1) | ATE517104T1 (https=) |
| AU (1) | AU2002316828B2 (https=) |
| BR (1) | BR0208566B1 (https=) |
| CA (1) | CA2440014C (https=) |
| CZ (1) | CZ295992B6 (https=) |
| EC (1) | ECSP034754A (https=) |
| ES (1) | ES2368389T3 (https=) |
| GB (1) | GB0108337D0 (https=) |
| HU (1) | HUP0400317A3 (https=) |
| IL (1) | IL157545A0 (https=) |
| MX (1) | MXPA03009057A (https=) |
| MY (1) | MY134026A (https=) |
| NO (1) | NO20034413L (https=) |
| NZ (1) | NZ528370A (https=) |
| PE (1) | PE20021018A1 (https=) |
| PL (1) | PL210861B1 (https=) |
| PT (1) | PT1377578E (https=) |
| RU (1) | RU2003130644A (https=) |
| SK (1) | SK12222003A3 (https=) |
| WO (1) | WO2002081471A1 (https=) |
| ZA (1) | ZA200306108B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| ES2427166T3 (es) * | 2003-06-23 | 2013-10-29 | Ono Pharmaceutical Co., Ltd. | Compuesto heterocíclico tricíclico novedoso |
| AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| WO2006068164A1 (ja) * | 2004-12-22 | 2006-06-29 | Ono Pharmaceutical Co., Ltd. | 三環式化合物およびその用途 |
| US7879859B2 (en) | 2005-11-21 | 2011-02-01 | Merck Sharp & Dohme Corp. | Diagnosis and treatment of type 2 diabetes and other disorders |
| WO2007062175A2 (en) * | 2005-11-21 | 2007-05-31 | Amgen Inc. | Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| EP2178537A4 (en) * | 2007-07-19 | 2011-08-17 | Merck Sharp & Dohme | BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS |
| WO2009016329A1 (en) * | 2007-07-31 | 2009-02-05 | Cambridge Enterprise Limited | Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions |
| US8338604B2 (en) | 2008-06-20 | 2012-12-25 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
| KR20180011888A (ko) | 2008-11-19 | 2018-02-02 | 포럼 파마슈티칼즈 인크. | (ｒ)-７-클로로-ｎ-(퀴누클리딘-３-일)벤조［ｂ］티오펜-２-카르복사미드 및 그 약학적으로 허용가능한 염을 이용한 인지 장애의 치료 |
| TW201028414A (en) | 2009-01-16 | 2010-08-01 | Merck Sharp & Dohme | Oxadiazole beta carboline derivatives as antidiabetic compounds |
| CN102695414A (zh) | 2010-01-15 | 2012-09-26 | 默沙东公司 | 作为抗糖尿病化合物的噁二唑β-咔啉衍生物 |
| AR081402A1 (es) | 2010-05-17 | 2012-08-29 | Envivo Pharmaceuticals Inc | Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato |
| CA2872005A1 (en) | 2012-05-08 | 2013-11-14 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
| CN111349096B (zh) * | 2020-04-14 | 2021-03-09 | 石河子大学 | 一种吲哚类化合物及其制备方法、应用 |
| KR102467844B1 (ko) | 2021-04-21 | 2022-11-16 | 삼성전자주식회사 | 솔리드 스테이트 드라이브 장치 및 이를 포함하는 데이터 저장 장치 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4118741A1 (de) * | 1991-06-05 | 1992-12-10 | Schering Ag | Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln |
| US6057340A (en) * | 1998-02-03 | 2000-05-02 | American Home Products Corporation | Oxazole derivatives as serotonin-1A receptor agonists |
| HUP0302962A2 (hu) | 1998-06-12 | 2003-12-29 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása |
-
2001
- 2001-04-03 GB GBGB0108337.7A patent/GB0108337D0/en not_active Ceased
-
2002
- 2002-03-27 AR ARP020101141A patent/AR035451A1/es not_active Application Discontinuation
- 2002-04-02 EP EP02745204A patent/EP1377578B1/en not_active Expired - Lifetime
- 2002-04-02 BR BRPI0208566-6B1A patent/BR0208566B1/pt not_active IP Right Cessation
- 2002-04-02 CN CNB028077814A patent/CN1309721C/zh not_active Expired - Fee Related
- 2002-04-02 PL PL362571A patent/PL210861B1/pl not_active IP Right Cessation
- 2002-04-02 AT AT02745204T patent/ATE517104T1/de active
- 2002-04-02 CZ CZ20032655A patent/CZ295992B6/cs not_active IP Right Cessation
- 2002-04-02 PE PE2002000264A patent/PE20021018A1/es not_active Application Discontinuation
- 2002-04-02 CA CA2440014A patent/CA2440014C/en not_active Expired - Fee Related
- 2002-04-02 RU RU2003130644/04A patent/RU2003130644A/ru not_active Application Discontinuation
- 2002-04-02 US US10/472,630 patent/US6861430B2/en not_active Expired - Fee Related
- 2002-04-02 NZ NZ528370A patent/NZ528370A/en not_active IP Right Cessation
- 2002-04-02 AU AU2002316828A patent/AU2002316828B2/en not_active Ceased
- 2002-04-02 IL IL15754502A patent/IL157545A0/xx unknown
- 2002-04-02 JP JP2002579459A patent/JP4405732B2/ja not_active Expired - Fee Related
- 2002-04-02 ES ES02745204T patent/ES2368389T3/es not_active Expired - Lifetime
- 2002-04-02 SK SK1222-2003A patent/SK12222003A3/sk not_active Application Discontinuation
- 2002-04-02 MX MXPA03009057A patent/MXPA03009057A/es active IP Right Grant
- 2002-04-02 HU HU0400317A patent/HUP0400317A3/hu unknown
- 2002-04-02 MY MYPI20021189A patent/MY134026A/en unknown
- 2002-04-02 KR KR1020037012933A patent/KR100564840B1/ko not_active Expired - Fee Related
- 2002-04-02 PT PT02745204T patent/PT1377578E/pt unknown
- 2002-04-02 WO PCT/EP2002/003624 patent/WO2002081471A1/en not_active Ceased
-
2003
- 2003-08-07 ZA ZA200306108A patent/ZA200306108B/en unknown
- 2003-08-27 EC EC2003004754A patent/ECSP034754A/es unknown
- 2003-10-02 NO NO20034413A patent/NO20034413L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05081B1 (et) | Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid | |
| DK1263720T3 (da) | Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme | |
| EE200300145A (et) | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon | |
| EE05643B1 (et) | Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina | |
| EE04565B1 (et) | Adamantaani derivaadid, nende saamine ja kasutamine | |
| EE200300327A (et) | Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon | |
| EE200300207A (et) | Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon | |
| NO20021689D0 (no) | 5-rings heterosykliske derivater, fremstilling derav og anvendelse som medikamenter | |
| EE200200064A (et) | Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena | |
| BRPI0508263B8 (pt) | derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina | |
| ITTO20010008A0 (it) | Formulazione farmaceutica | |
| DE60209145D1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
| EE04464B1 (et) | Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| EE200100391A (et) | Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon | |
| ATE355271T1 (de) | Pharmazeutische zusammensetzung | |
| EE200300048A (et) | Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
| DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
| EE200200607A (et) | 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena | |
| BR0208566B1 (pt) | Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica | |
| EE200100470A (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| NO20022021D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler | |
| NO20016404L (no) | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
| ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
| ATE366128T1 (de) | Pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/12/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2307 DE 24-03-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |